Keytruda Industry Statistics

Keytruda is a leading immunotherapy drug in the pharmaceutical industry, with significant market share and continually growing revenues.

Statistic 1

"In the third quarter of 2021, the total Keytruda sales accounted for $4 billion."

Sources Icon

Statistic 2

"The U.S. accounted for 61% of Keytruda's total sales in 2020."

Sources Icon

Statistic 3

"Keytruda sales were up 26% globally in 2020 compared to 2019."

Sources Icon

Statistic 4

"Merck spent approximately $12 billion on Keytruda development and distribution in 2020."

Sources Icon

Statistic 5

"Keytruda revenues were expected to reach $22.5 billion by 2025."

Sources Icon

Statistic 6

"In 2021, Keytruda was approved to treat over 50 oncology indications in the U.S."

Sources Icon

Statistic 7

"In 2020, Keytruda was the best-selling immunotherapy globally."

Sources Icon

Statistic 8

"The growth of the global oncology/cancer drugs market is projected to reach $176.50 Billion by 2026, and Keytruda is one of the key drugs in this market."

Sources Icon

Statistic 9

"In 2018, Keytruda was responsible for less than 20% of Merck's total sales, but in 2020, it accounted for nearly 30%."

Sources Icon

Statistic 10

"In 2019, Keytruda revenues for Merck surpassed those from its next best drugs Januvia and Janumet combined."

Sources Icon

Statistic 11

"Merck & Co. forecasted $45.1bn in Keytruda sales in 2026."

Sources Icon

Statistic 12

"Between 2017 and 2021, Keytruda received more than 15 approvals from the FDA."

Sources Icon

Statistic 13

"Since its launch, Keytruda's pricing has grown by 54%."

Sources Icon

Statistic 14

"In 2019, the cost for one vial of Keytruda in the United States was $2,114."

Sources Icon

Statistic 15

"In 2021, Keytruda was approved for use in High-risk early-stage triple-negative breast cancer marking its first approval in early-stage curative setting."

Sources Icon

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!